Eisai Co., Ltd. (TYO:4523)

Eisai Revenue

Eisai had revenue of 235.63B JPY in the quarter ending September 30, 2026, with 19.39% growth. This brings the company's total for the last twelve months to 895.33B, up 11.30% year-over-year. In the fiscal year ending March 31, 2026, Eisai had annual revenue of 825.38B with 4.56% growth. That makes Eisai the 2,418th largest company in the world by revenue and 236th in Japan.

• Revenue (ttm): 895.33B
• Revenue Growth: +11.30%
• P/S Ratio: 1.64
• Revenue / Employee: 84.92M
• Employees: 10,543
• Market Cap: 1.46T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Business - Americas 300.44B 36.4%
• Pharmaceutical Business - Japan (Including Pharmaceutical Business - OTC and Others) 229.24B 27.8%
• Pharmaceutical Business - China 130.75B 15.8%
• Pharmaceutical Business - EMEA 81.53B 9.9%
• Pharmaceutical Business - East Asia Global South 68.82B 8.3%
• Other Business 14.60B 1.8%

By Geography

Chart

• United States (U.S.) 293.14B 35.5%
• Japan 237.03B 28.7%
• China 127.24B 15.4%
• Others 80.04B 9.7%
• Europe 70.99B 8.6%
• Americas (Excluding United States) 16.95B 2.1%

Fiscal year ended Mar 31, 2026 See the full Eisai breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	825.38B	35.98B	4.56%
Mar 31, 2025	789.40B	47.65B	6.42%
Mar 31, 2024	741.75B	-2.65B	-0.36%
Mar 31, 2023	744.40B	-11.82B	-1.56%
Mar 31, 2022	756.23B	110.28B	17.07%

Data Source: S&P Global Market Intelligence Last updated: Nov 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error